Propanc Biopharma’s CEO Tours European CDMO & Plans for GMP Production of PRP for Phase 1b, FIH Study

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/7/2026

1. HUVR:IN
2. ANET
3. NKE
4. PANW
5. CL
6. SNDK
7. TAP
8. DELL
9. ROIV
10. HUBS

Go back to Propanc Biopharma’s CEO Tours European CDMO & Plans for GMP Production of PRP for Phase 1b, FIH Study
(NASDAQ: PPCB) Delayed: 1.01 -0.01 (0.98%)
Previous Close $1.02    52 Week High $ 
Open $1.05    52 Week Low $ 
Day High $1.05    P/E N/A 
Day Low $0.97    EPS $ 
Volume 194,403       

(NASDAQ: PPCB) Delayed: 1.01 -0.01 (0.98%)
Previous Close $1.02    52 Week High $ 
Open $1.05    52 Week Low $ 
Day High $1.05    P/E N/A 
Day Low $0.97    EPS $ 
Volume 194,403